CANADA PENSION PLAN INVESTMENT BOARD - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
CANADA PENSION PLAN INVESTMENT BOARD ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,664,663
+656.1%
145,724
+614.3%
0.03%
+550.0%
Q2 2023$2,336,208
-56.1%
20,400
-47.2%
0.00%
-50.0%
Q1 2023$5,320,238
-37.9%
38,600
-41.6%
0.01%
-46.7%
Q4 2022$8,565,238
+20.9%
66,100
+3.1%
0.02%
+25.0%
Q3 2022$7,086,000
+107.7%
64,100
+40.9%
0.01%
+100.0%
Q2 2022$3,411,000
+635.1%
45,500
+665.5%
0.01%
+500.0%
Q1 2022$464,000
-90.6%
5,944
-89.1%
0.00%
-80.0%
Q4 2021$4,920,000
+42.7%
54,633
+46.6%
0.01%
+25.0%
Q3 2021$3,447,000
+844.4%
37,266
+661.2%
0.00%
Q1 2021$365,000
-26.1%
4,896
+58.9%
0.00%
-100.0%
Q2 2020$494,000
+216.7%
3,082
+155.1%
0.00%
Q4 2019$156,000
-86.7%
1,208
-92.4%
0.00%
-100.0%
Q1 2018$1,171,000
+1.6%
15,800
-23.7%
0.00%0.0%
Q4 2017$1,152,000
-15.6%
20,700
-31.2%
0.00%
-33.3%
Q3 2017$1,365,000
+116.7%
30,100
+61.0%
0.00%
+200.0%
Q2 2017$630,000
+37.9%
18,700
-20.1%
0.00%
-50.0%
Q1 2016$457,000
-89.7%
23,400
-79.7%
0.00%
-90.5%
Q4 2015$4,437,000
+307.4%
115,000
+239.2%
0.02%
+425.0%
Q3 2015$1,089,000
+29.6%
33,900
+22.8%
0.00%
+33.3%
Q2 2015$840,000
+3260.0%
27,600
+1523.5%
0.00%
Q4 2014$25,0001,7000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders